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Abstract
Introduction:  Chronic  granulomatous  disease  associated  with  common  variable  immunodeﬁ-
ciency (GD-CVID),  although  well  documented,  is  rare.  Granulomatous  lesions  can  affect  several
organs and  are  histologically  indistinguishable  from  sarcoidosis.
Clinical  cases:  Case  1:  A  39-year-old  male  patient  with  CVID,  asymptomatic  although  with
thrombocytopenia  and  mediastinal-hilar  adenopathies.  GD-CVID  was  diagnosed  by  bone  marrow
biopsy. Progressive  clinical  and  radiological  improvement  was  obtained  with  corticotherapy.
Case 2:  A  38-year-old  male  patient  with  CVID,  suffered  from  asthenia,  anorexia,  myalgia,
lower limbs  edemas,  and  dry  cough.  He  had  mediastinal  and  bilateral  hilar  adenopathies  within
which biopsy  revealed  non-necrotizing  granulomatous  inﬁltrate.  A  spontaneous  resolution  was
detected after  9  months  of  evolution.
Conclusion:  GD-CVID  is  rare  and  can  mimetize  other  pathologies,  namely,  sarcoidosis;  it  should
therefore be  publicized  and  discussed  so  that  it  becomes  a  general  clinical  knowledge.
© 2013  Sociedade  Portuguesa  de  Pneumologia.  Published  by  Elsevier  España,  S.L.  All  rights
reserved.
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Doenc¸a granulomatosa  crónica  associada  com  a  imunodeﬁciência  comum  variável  -
2  casos  clínicos
Resumo
Introduc¸ão:  A  doenc¸a  granulomatosa  crónica  associada  à  imunodeﬁciência  comum  variável  (DG-mentada,  é  rara.  As  lesões  granulomatosas  podem  afectar  váriosDoenc¸a IDCV), apesar  de  bem  docuPlease  cite  this  article  in  press  as:  Pacheco  C,  et  al.  Chronic  granulomatous  disease  associated  with  common  variable
immunodeﬁciency  --  2  clinical  cases.  Rev  Port  Pneumol.  2014.  http://dx.doi.org/10.1016/j.rppneu.2013.09.005
granulomatosa orgãos e  são  histologicamente  indistinguíveis  daquelas  que  caracterizam  a  sarcoidose.
Casos clínicos:  Caso  1:  Doente  do  sexo  masculino,  39  anos,  com  diagnóstico  de  imunodeﬁciência
comum  variável,  clinicamente  assintomático,  com  trombocitopenia  e  adenopatias  pré-traqueais
e hilares  de  novo.  O  diagnóstico  de  DG-IDCV  foi  obtido  por  biópsia  de  medula  óssea.  Iniciou
tratamento com  corticoterapia  com  melhoria  clínica  e  radiológica  progressiva.
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Caso  2:  Doente  do  sexo  masculino,  38  anos,  com  diagnóstico  de  imunodeﬁciência  comum  var-
iável, com  queixas  de  astenia,  anorexia,  mialgias,  edemas  dos  membros  inferiores  e  tosse  seca.
Adenopatias  mediastínicas  e  hilares  bilaterais  cuja  biopsia  revelou  inﬁltrado  granulomatoso  não
necrotizante.  Observou-se  uma  resoluc¸ão  espontânea  após  nove  meses  de  evoluc¸ão.
Conclusão:  A  doenc¸a  granulomatosa  crónica  associada  a  imunodeﬁciência  comum  variável  é
rara. Dado  que  esta  entidade  pode  mimetizar  outras  patologias,  nomeadamente  a  sarcoidose,
os casos  clínicos  que  se  referem  à  mesma  devem  ser  publicados  e  discutidos  para  conhecimento
clínico geral.
© 2013  Sociedade  Portuguesa  de  Pneumologia.  Publicado  por  Elsevier  España,  S.L.  Todos  os
direitos reservados.
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Dntroduction
ommon  variable  immunodeﬁciency  (CVID)  is  a  rare  primary
mmunodeﬁciency  syndrome  characterized  by  impaired
-cell  differentiation  with  inaccurate  immunoglobulin
roduction.1 It  is  deﬁned  by  markedly  reduced  serum
oncentrations  of  IgG,  combined  with  low  levels  of  IgA
nd/or  IgM,  poor  or  absent  response  to  immunizations  in
 patient  without  any  other  signs  of  immunodeﬁciency.
he  prevalence  in  Europe  is  estimated  to  be  around
:50,000--1:200,000.2 The  etiology  is  still  unknown,  but  it
ppears  to  result  from  a  variety  of  gene  defects  (e.g.,  ICOS,
ACI,  BAFF-R,  CD19,  CD20,  CD21,  and  CD81),  most  of  which
re  sporadic  rather  than  familiar.2--4
Although  rare,  systemic  granulomatous  disease  related
o  CVID  is  well  documented  (>50  case  reports).  Granulo-
atous  non-caseous  lesions  can  be  detected  in  the  lung,
iver,  spleen,  gastrointestinal  tract,  lymph  nodes,  skin  and
ye  in  almost  10%  of  the  patients  with  CVID.2,5 Some
f  them  also  show  clinical  manifestations  similar  to  sar-
oidosis,  with  symptoms  like  dyspnea,  persistent  cough,
sthenia,  anorexia  and  arthralgia.6,7 Granulomatous  lesions
n  CVID  may  not  only  affect  the  same  organs  as  sarcoido-
is  but  also  be  histologically  indistinguishable.8--11 As  a
onsequence,  sarcoidosis  is  often  incorrectly  diagnosed  in
D-CVID  patients,  with  GD-CVID  considered  as  a  distin-
uished  entity.12--15
The  authors  present  two  clinical  cases  of  CVID  with  sys-
emic  involvement  by  non-  caseous  granulomas.
linical cases
st  case
 39-year-old  male,  mechanic  engineer,  non-smoker,  had
een  diagnosed  with  CVID  4  years  ago,  under  treatment
ith  intravenous  IgG.  He  had  previously  had  several  res-
iratory  infections  since  childhood.  In  November  2009,
fter  a  routine  chest  X-ray  with  mediastinum  enlarge-
ent,  a  thoracic  CT  scan  was  performed  and  numerousPlease  cite  this  article  in  press  as:  Pacheco  C,  et  al.  Chronic  
immunodeﬁciency  --  2  clinical  cases.  Rev  Port  Pneumol.  2014.  
denopathies  in  the  prevascular,  pretracheal  as  well  as
n  the  right  pulmonary  hilum  were  observed.  Additionally,
iffuse  peribronchovascular  micronodules  were  detected
n  lung  parenchyma  (Fig.  1  and  2).  The  patient  had  no
C
i
i
pelevant  clinical  complaints  or  alterations  at  physical  exam-
nation.  Besides  hypogammaglobulinemia  (IgG  287  mg/dL;
gM  8  mg/dL;  IgA  6  mg/dL)  and  slight  thrombocytopenia
platelets  127  ×  103 L),  no  other  serum  related  alterations
ere  noticed.  Lung  function  tests  revealed  a mild  obstruc-
ive  pattern.  A  bronchoscopy  with  bronchoalveolar  lavage
BAL)  was  performed.  It  showed  lymphocytic  alveolitis  (28%)
ith  a  slight  increase  in  CD4/CD8  ratio  (2.2),  and  no  microor-
anism  was  isolated  or  malignant  cell  detected.  A  bone
arrow  biopsy  was  also  performed,  which  showed  non-
aseous  granulomas.  There  were  no  clinical  or  imagiological
ndications  of  other  organ  involvement.  At  this  stage,  the
atient  was  started  on  oral  corticotherapy  which  led  to
rogressive  clinical  and  radiological  improvement  ending  in
otal  disease  resolution  which  continued  after  the  patient
ome  off  medication.
nd  case
 38-year-old  male  nurse,  a  non-smoker,  had  been  diag-
osed  with  CVID  a  year  earlier,  treated  with  intravenous
gG.  Previously,  he  had  had  several  respiratory  infections
ince  childhood.  In  February  2010,  he  began  to  suffer
rom  asthenia,  anorexia,  and  erythema  nodosum.  A  tho-
acic  CT  scan  showed  mediastinal  and  bilateral  symmetrical
ilar  adenopathies.  Lung  function  tests  were  normal.  Bron-
hoscopy  with  BAL  revealed  lymphocytosis  (35%)  with  a
light  increase  in  CD4/CD8  ratio  (2.6)  and  no  microor-
anism  or  malignant  cells  were  detected.  Endobronchial
ltrasound  biopsy  showed  non-necrotizing  granulomatous
nﬁltration.  There  were  no  signs  of  extrathoracic  involve-
ent.  After  diagnosis,  he  was  prescribed  symptomatic
herapy  only  (antitussives  and  anti-inﬂammatories).  After
 months,  there  was  a  spontaneous  resolution  of  the  dis-
ase,  that  is  to  say,  the  patient  became  asymptomatic  and
o  imagiologic  alterations  or  signs  of  recurrence  have  been
etected  so  far.
iscussiongranulomatous  disease  associated  with  common  variable
http://dx.doi.org/10.1016/j.rppneu.2013.09.005
VID  is  a  heterogeneous  disease,  characterized  by  recurrent
nfections,  particularly  bacterial  infections  often  occurring
n  the  respiratory  or  gastrointestinal  tract,  autoimmunity
henomena,  predisposition  to  malignant  diseases,  and
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RFigure  1  and  2  Thoracic  CT  scan  from  patient  1,  November  2
lung parenchyma.
granulomatous  inﬂammation  (GD-CVID).5,16--18 Although
GD-CVID  is  well  documented,  the  etiology  is  still  unknown
and  treatment  undeﬁned.18
The  link  between  CVID  and  the  granulomatous  disease
seems  logical  according  to  the  immunological  mechanisms
that  are  implied  in  the  CVID  pathophysiology.  However,  the
absence  of  granulomatous  disease  in  other  immunodeﬁcien-
cies  (as  hypogammaglobulinemia  related  to  X)  suggests  that
GD-CVID  is  not  caused  by  recurrent/persistent  infections.6
A  recent  hypothesis  is  that  high  levels  of  tumor  necrosis
factor  (TNF)  might  be  related  to  the  development  of  granu-
lomas  in  these  patients.6,12
Non-caseous  granulomatous  lesions  that  affect  CVID
patients  are  histologically  indistinguishable  from  those  of
sarcoidosis.  The  patient’s  age  and  sex,  diminished  cellu-
lar  immunity,  the  systemic  involvement,  and  high  levels
of  angiotensin-converting  enzyme  are  common  features
for  the  two  pathologies,  so  a  previous  story  of  recur-
rent/persistent  bacterial  infections  should  raise  suspicion
of  CVID.6,7 However,  in  a  case--control  study  comparing
GD-CVID  patients  and  patients  with  pulmonary  sarcoidosis,
certain  differences  were  detected,  such  as  a  random  versus
perilymphatic  micronodular  distribution  on  lung  CT  scan  in
GD-CVID  patients,  besides  the  higher  frequency  of  consoli-
dations  with  air  bronchogram,  bronchiectasis,  or  halo  signs.
Biological  data  showed  that  BAL  CD4/CD8  ratio  was  signiﬁ-
cantly  lower  in  GD-CVID.  There  is  a  general  agreement  that
the  presence  of  lung  involvement  is  associated  with  a  bad
prognosis  in  CVID,  including  when  a  GD-CVID  occurs.  How-
ever  Bouvry  et  al.  in  their  case--control  study  did  not  ﬁnd
GD  to  be  a  critical  determinant  of  prognosis  but  found  a
worse  outcome  to  be  linked  to  the  classical  complications  of
CVID  such  as  lymphoma,  infection  or  obstructive  lung  disease
secondary  to  bronchiectasis.1
The  clinical  presentations  of  the  two  reported  clinical
cases,  asymptomatic  mediastinal  and  hilar  adenopathies  and
erythema  nodosum,  are  among  the  most  frequent  presen-
tations  of  sarcoidosis.  In  addition  CVID  was  already  known
in  both  patients;  however  GD-CVID  can,  although  rarely,  be
the  presentation  of  the  disease.  The  random  distribution
of  the  lung  micronodules  in  the  ﬁrst  patient  and  the  slight
BAL  CD4/CD8  increase  are  in  line  with  previous  reports.Please  cite  this  article  in  press  as:  Pacheco  C,  et  al.  Chronic  
immunodeﬁciency  --  2  clinical  cases.  Rev  Port  Pneumol.  2014.  
However,  the  therapeutic  strategy  toward  this  granuloma-
tous  disease  has  diverged.  Although  corticotherapy  is  not
universally  accepted  as  a  mandatory  treatment,12,15 it  was
prescribed  for  the  ﬁrst  patient  because  of  the  systemicshowing  diffuse  peribronchovascular  micronodules  detected  in
nvolvement,  namely,  the  cytopenia  secondary  to  the  bone
arrow  involvement.  The  second  patient  did  not  receive  any
herapy  directed  at  the  GD.  However,  both  of  them  improved
n  clinical,  analytical,  and  radiological  terms,  which  is  in  line
ith  the  favorable  evolution  reported  by  Bouvry  et  al.1 The
ppropriate  treatment  for  GD-CVID  patients  has  not  yet  been
stablished.6,7,12,15
There  are  no  protocols  regarding  diagnosis,  treatment
nd  follow-up,  nor  prognosis  for  GD-CVID  patients.  Many
f  these  patients  are  followed  individually  and  in  a  non-
tandardized  way.  All  clinicians  should  be  familiar  with  this
athology  because  so  many  organs  and  systems  can  be
ffected.7,8,17
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